Skip to main content
. 2020 Mar 30;2020:6127327. doi: 10.1155/2020/6127327

Figure 1.

Figure 1

Study duration and treatment regimen. The experimental group was given 75 mg OCG capsules three times daily along with a TCS (i.e., mometasone furoate 0.1%) ointment once daily for 28 days. The control group received placebo + TCS. Relevant clinical data were collected on days 1, 7, 14, 21, and 28 and at a four-week follow-up.